Abbott laboratories reagents w/ use of analyzers.
Ended Blanket Purchase Agreement Awarded Last action
- Contract number
- W81K0223A0005
- Awardee
-
Abbott Laboratories Inc. UEI NH3LDK8CFAK7 Part of Abbott Laboratories
- Awarding agency
-
Medical Command
Department of the Army, Department of Defense
- Task orders
- 6 $1,246,000 obligated
Award facts
- Combined order value
- $1,246,000 Current and potential, with all options
- Last date to order 100% complete
- IDV ceiling 100% used
- $1,250,000.00
- Maximum order
- $250,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- Funding agency
- Defense Health Agency Department of Defense
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- Set-aside
- No set-aside
- Pricing
- Order Dependent (IDV only)
Award details come from SAM.gov/FPDS.
About this IDV
Abbott Laboratories Inc., through its Abbott Diagnostics Division, holds a single-award Blanket Purchase Agreement (BPA) with the Defense Health Agency valued at $1.25 million, effective from July 1, 2023 through April 30, 2024. The contract procures clinical chemistry and immunoassay reagents and analyzers to support laboratory operations within the Department of Defense healthcare system. Performance of work is conducted at Abbott's facility in North Chicago, Illinois. No small business or socioeconomic set-aside was utilized in this full and open competition award. The BPA serves as an indefinite delivery vehicle enabling the Defense Health Agency to issue periodic bulk-funded calls for testing services and diagnostic supplies on a firm fixed-price basis, with all work completed on an as-needed monthly or bi-monthly schedule throughout the contract period.
Six documented BPA calls were issued against this master contract vehicle between July 2023 and April 2024, ranging from $125,000 to $250,000 per call period, collectively obligating approximately $1.116 million of the available ceiling. These calls represent the Defense Health Agency's recurring procurement of clinical laboratory testing capabilities—specifically clinical chemistry and immunoassay tests—required to support diagnostic operations across military treatment facilities. Abbott's Diagnostics Division provides automated analyzer systems, reagents, and consumables necessary for comprehensive patient laboratory testing, enabling military healthcare providers to conduct essential clinical assessments. The monthly or bi-monthly call structure reflects the Defense Health Agency's demand-driven procurement approach, allowing flexibility to adjust testing volumes based on actual operational requirements while maintaining predictable supplier relationships with an established diagnostic equipment and services provider.
Task orders
Quick answers
Who was awarded contract W81K0223A0005?
W81K0223A0005 was awarded to Abbott Laboratories Inc. by Medical Command (Department of the Army) on July 1, 2023.
How much is contract W81K0223A0005 worth?
Orders under W81K0223A0005 have obligated $1,246,000. W81K0223A0005's own ceiling is $1,250,000. A single order can be worth up to $250,000.
How many orders have been placed under contract W81K0223A0005?
6 orders have been placed under W81K0223A0005, the latest on April 1, 2024.
Which agency awarded contract W81K0223A0005?
Medical Command (Department of the Army) awarded W81K0223A0005, with funding from Defense Health Agency (Department of Defense).
Who can order from contract W81K0223A0005?
W81K0223A0005 is a single award blanket purchase agreement. Only the awarding agency can place orders on it.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV